Cannabidiol in children with treatment-resistant epilepsy with myoclonic-atonic seizures

CONCLUSION: This study evaluating the use of add-on CBD in children with EMAtS or SWS with myoclonic-atonic seizures found that 15/26 (57.7%) had a >50% seizure reduction with good tolerability; three (11.5%) became seizure-free.PMID:37182500 | DOI:10.1016/j.yebeh.2023.109245
Source: Epilepsy and Behaviour - Category: Neurology Authors: Source Type: research